Back to FGEN Stock Lookup

FibroGen (FGEN) – FDA

Apr 6, 2021 04:04 PM FibroGen (FGEN) provided clarification of certain prior disclosures of U.S. primary cardiovascular safety analyses from roxadustat Phase 3 program for the treatment of anemia of CKD
Mar 16, 2021 07:08 AM FibroGen (FGEN) Begins LELANTOS-2, a Second Phase 3 Clinical Study of Pamrevlumab for Treatment of DMD
Mar 1, 2021 04:06 PM
Dec 22, 2020 07:02 AM
Dec 21, 2020 06:56 AM
Dec 2, 2020 07:06 AM
Nov 27, 2020 07:01 AM
Nov 27, 2020 06:00 AM
Oct 14, 2020 07:08 AM
Aug 11, 2020 07:14 AM
Jun 23, 2020 07:07 AM
Jun 8, 2020 05:02 PM
Jun 8, 2020 07:07 AM
Feb 11, 2020 05:06 PM
Dec 23, 2019 07:02 AM
Dec 2, 2019 07:03 AM
Nov 8, 2019 03:00 PM
Nov 8, 2019 02:09 PM
Nov 8, 2019 02:03 PM
Nov 8, 2019 05:57 AM
Oct 23, 2019 07:13 AM
Sep 30, 2019 07:06 AM
Sep 26, 2019 07:08 AM
Jul 25, 2019 06:26 AM
Jul 22, 2019 07:02 AM
May 9, 2019 04:45 PM
Apr 15, 2019 07:03 AM
Dec 20, 2018 10:32 AM
Dec 20, 2018 06:48 AM
Oct 26, 2018 05:40 AM
Oct 1, 2018 08:12 AM
Sep 12, 2018 09:32 AM
Jun 4, 2018 06:28 AM
May 31, 2018 06:55 AM
May 21, 2018 04:03 PM
Mar 1, 2018 07:09 AM
Oct 31, 2017 06:17 AM
Oct 18, 2017 07:06 AM
Sep 13, 2017 07:04 AM
Aug 29, 2017 09:28 AM
Aug 8, 2017 06:25 AM
Aug 7, 2017 05:06 PM
Aug 7, 2017 04:24 PM
Jun 21, 2017 10:28 AM
Jun 21, 2017 07:58 AM
Jun 5, 2017 07:12 AM
Mar 31, 2017 07:28 AM
Mar 30, 2017 07:13 AM
Jan 30, 2017 07:08 AM
Apr 21, 2016 07:38 AM

Back to FGEN Stock Lookup